-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/skin-cancer-screening-july-2016
July 26, 2016 - challenges, the USPSTF concludes that further evidence is necessary to advance the field on this essential question … The USPSTF identified only 1 fair-quality case-control study pertaining to the question of whether screening
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/-hnLT26c2NHs6thK9yznPF
July 01, 2002 - of
raloxifene compared with placebo on both coronary
heart disease and breast cancer.73 An important
question … Key Questions
The primary, overarching question, shown as the
topmost line in Figure 1, is the following … large or long enough to
examine the impact of chemoprevention on
mortality from breast cancer (Key Question
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction-2002
May 06, 2002 - raloxifene compared with placebo on both coronary heart disease and breast cancer. 73 An important question … Key Questions
The primary, overarching question, shown as the topmost line in Figure A-1 (9 KB), … large or long enough to examine the impact of chemoprevention on mortality from breast cancer (Key Question
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/inevidup.pdf
September 01, 2009 - A systematic review is generally done to answer
each key question. … When considered together, the key
question evidence forms a chain of evidence that permits
firm conclusions
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/jmCXJwxefa67VY4NfD8gUg
June 26, 2018 - Benefits of Screening
Key Question 1. … Diagnostic and Predictive Accuracy of Screening
Key Question 2a. … Key Question 2b. … Benefits of Treatment
Key Question 4a. … Key Question 4b.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/hbSopN6uA9u-4EQuKtRGDP
October 01, 2011 - For harms (key question 4), we included addi-
tional study designs (large cohort studies or case–control … RESULTS
Key Question 1: Screening for Obesity/Overweight
We identified no trials comparing screening … Key Question 4: Harms of Weight-Loss Interventions
Behavioral Studies
Ten studies reported on possible … KQ � key question. … database searching (n = 11 875)
Additional records identified through
other searching (n = 371)
KQ � key question
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/HhFR4LyVtxMcwmafRH6Ehp
June 04, 2024 - KQ indicates key question; USPSTF, US Preventive Services Task Force.
aStudies may appear in more than … Harms of Interventions
Key Question 2. … exercise classes) typically available in the US
Abbreviations: IRR, incidence rate ratio; KQ, key question
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/-97QgoUF_rpQSy-9yM9KCx
November 24, 2020 - Benefits of Interventions
Key Question 1. … Key Question 2. … CVD Events (Key Question 1)
Favors
intervention
Favors
control
0.01 101 1000.1
Risk ratio (95% CI) … Key Question 3. … Harms of Interventions
Key Question 4.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/depression-screening-2002
May 07, 2002 - Obstetricians and Gynecologists recommends that clinicians should be alert to symptoms of depression and question
-
www.uspreventiveservicestaskforce.org/Home/GetFileByToken/-BbKrbuLt9RAPvf3BQrUMW
Prostate Cancer Screening Recommendation Frequently Asked Questions
1
Prostate Cancer Screening Recommendation
Frequently Asked Questions
Table of Contents
About the
2018 recommendation ...............1
How to interpret
the recommendation ..................2
The benefits and
harm…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication-november-2016
November 13, 2016 - years and, most particularly, 85 years and older) among its "10 Things Physicians and Patients Should Question … statins in preventing CVD events across different populations led the USPSTF to reframe its main clinical question … Ten things physicians and patients should question.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/YFZy6kszQPq5tNGdZC25XC
July 26, 2016 - challenges, the USPSTF concludes that further evi-
dence is necessary to advance the field on this essential question … The USPSTF identified only 1
fair-quality case-control study pertaining to the question of
whether screening
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/G9P7o8jDh4J3NnAk6y-SYL
December 01, 2011 - Key Question 1: Does PSA-Based Screening Decrease
Prostate Cancer–Specific or All-Cause Mortality? … Key Question 2: What Are the Harms of PSA-Based
Screening for Prostate Cancer? … Key Question 3: What Are the Benefits of Treatment of
Early-Stage or Screening-Detected Prostate Cancer … Key Question 4: What Are the Harms of Treatment of
Early-Stage or Screening-Detected Prostate Cancer? … ERSPC � European Randomized Study of Screening for Prostate Cancer; HR � hazard ratio; KQ � key question
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/b5LjDb3-UoPV8LEWavJWB8
February 01, 2010 - adolescents
ABBREVIATIONS
USPSTF—US Preventive Services Task Force
FDA—Food and Drug Administration
KQ—key question … of sources considered/search
strategy used
The study addresses an appropriate and clearly focused question … Case-control studies Accurate ascertainment of cases The study addresses an appropriate and clearly focused question … confounders were distributed
equally among groups
The study addresses an appropriate and clearly focused question … analysis; consideration of inception cohorts
The study addresses an appropriate and clearly focused question
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/pACFPdCoN8fVoddBs-_CLE
November 12, 2019 - Scoring System
(Table 2), Referral Screening Tool (Table 3), Pedigree Assessment
Tool (Table 4), 7-Question … History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question … Table 2),16-21,41 Referral Screening Tool (Table 3),22 Pedi-
gree Assessment Tool (Table 4),23,24 7-Question … Seven-Question Family History Screeninga,b
No.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/FExZhpEq2337V-hwkaPQ8y
May 01, 2002 - Obstetricians and
Gynecologists recommends that clinicians should be
alert to symptoms of depression and question
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hypertensive-disorders-pregnancy-screening
September 19, 2023 - Articles could be reviewed for more than 1 key question … reporting Hispanic ethnicity
Abbreviations: HRQoL, health-related quality of life; KQ, key question
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/physical-activity-behavioral-counseling-primary-care-2002
July 01, 2002 - for poor rating *
Result *
Bull and Jamrozik, 1998 31
Maintenance of comparison groups in question … Calfas et al., 1996 30
Establishment and maintenance of comparison groups in question.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/VN82XmdDhcK74WtHxWBTqm
May 01, 2004 - Unfortunately, none of the
existing randomized trials answer the question
faced by clinicians: Should … An important and controversial issue in lung
cancer screening is the question of over-diagnosis
(and … Fair: Generally comparable groups assembled initially, but some question remains whether some (although
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/3HxQuXnyqHpUKNqjB7hWBw
September 01, 2005 - Effects
KQ 4
KQ 5
Adverse
Effects
Testing
Intervention
Screening
Risk Assessment
KQ 1
Key question … noted in
the “poor” category below: Generally comparable groups are as-
sembled initially but some question … Inclusion and Exclusion Criteria according to Key Question*
Question Criteria
KQ 1, 2a, 3 (risk assessment … report)
No data (commentary, letter, opinion)
Information not relevant (dated, off-topic)
* KQ � key question